Cargando…
In Vitro Susceptibility to Miltefosine of Leishmania infantum (syn. L. chagasi) Isolates from Different Geographical Areas in Brazil
Treatment of visceral leishmaniasis in Brazil still relies on meglumine antimoniate, with less than ideal efficacy and safety, making new therapeutic tools an urgent need. The oral drug miltefosine was assayed in a phase II clinical trial in Brazil with cure rates lower than previously demonstrated...
Autores principales: | Espada, Caroline Ricce, Levatti, Erica V. de Castro, Boité, Mariana Côrtes, Lamounier, Dorcas, Alvar, Jorge, Cupolillo, Elisa, Costa, Carlos Henrique Nery, Rode, Joelle, Uliana, Silvia R. B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228039/ https://www.ncbi.nlm.nih.gov/pubmed/34198947 http://dx.doi.org/10.3390/microorganisms9061228 |
Ejemplares similares
-
Generation of Luciferase-Expressing Leishmania infantum chagasi and Assessment of Miltefosine Efficacy in Infected Hamsters through Bioimaging
por: Reimão, Juliana Q., et al.
Publicado: (2015) -
Rattus norvegicus (Rodentia: Muridae) Infected by Leishmania (Leishmania) infantum (syn. Le. chagasi) in Brazil
por: Lara-Silva, Fabiana de Oliveira, et al.
Publicado: (2014) -
Natural Resistance of Leishmania infantum to Miltefosine Contributes to the Low Efficacy in the Treatment of Visceral Leishmaniasis in Brazil
por: Carnielli, Juliana B. T., et al.
Publicado: (2019) -
Visceral leishmaniasis with cutaneous involvement caused by Leishmania infantum-chagasi
por: Raja, Mohammed, et al.
Publicado: (2017) -
Mitochondrial Proteomics of Antimony and Miltefosine Resistant Leishmania infantum
por: Vincent, Isabel M., et al.
Publicado: (2015)